NANTES, France, January 13, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced the appointment of Dr. Sonya Montgomery as Chief Development Officer.
NANTES, France, January 13, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced the appointment of Dr. Sonya Montgomery as Chief Development Officer. Sonya ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback